Literature DB >> 9135969

Circulating markers in squamous cell carcinoma of the head and neck: a review.

C H Rassekh1, J T Johnson, D E Eibling.   

Abstract

Biological markers of disease enhance the ability to diagnose, treat and evaluate results of therapy and are especially intriguing for their potential use in the management of malignant tumours. The serum levels of various biochemical substances have been shown to be abnormal for many cancers and are utilised in the management of affected patients. Several markers have been thoroughly investigated for potential clinical utility in head and neck carcinoma. Although no single marker has been found to be adequately sensitive and specific, combinations of markers may improve the utility for some aspects of patient management. This review highlights the literature to date in the realm of circulating markers for head and neck carcinoma. A discussion of the potential usefulness and limitations of such markers follows.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9135969     DOI: 10.1016/0964-1955(94)90046-9

Source DB:  PubMed          Journal:  Eur J Cancer B Oral Oncol        ISSN: 0964-1955


  7 in total

1.  Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.

Authors:  D Kandiloros; A Eleftheriadou; T Chalastras; L Kyriou; I Yiotakis; E Ferekidis
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 2.  [Tumor markers and biomarkers in squamous cell cancer of the head and neck].

Authors:  F Lordick; J Krauss; D Jäger
Journal:  HNO       Date:  2008-09       Impact factor: 1.284

Review 3.  Biological staging of head and neck cancer and its role in developing effective treatment strategies.

Authors:  W M Lydiatt; S P Schantz
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

4.  Early detection in head and neck cancer - current state and future perspectives.

Authors:  Andreas O H Gerstner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2010-10-07

5.  In vitro T-lymphocyte function in head and neck cancer patients.

Authors:  J H Heimdal; H J Aarstad; A Aakvaag; J Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 3.236

Review 6.  An insight into salivary markers in oral cancer.

Authors:  Ramnarayan Belur Krishna Prasad; Akhilesh Sharma; Harsha Mysore Babu
Journal:  Dent Res J (Isfahan)       Date:  2013-05

Review 7.  A Review of Salivary Biomarker: A Tool for Early Oral Cancer Diagnosis.

Authors:  Shikha Saxena; Bharat Sankhla; Krishna Sireesha Sundaragiri; Akshay Bhargava
Journal:  Adv Biomed Res       Date:  2017-07-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.